Anavex Life Sciences Corp (AVXL)

[falconer66a]

Pretty Lively Cat

Today's price bounce, that attributed by the share pricing experts to a "dead cat," was pretty lively.

The AVXL cat didn't "bounce" today; it gained value right to the end, never falling, closing but a penny off the high of the day, which was in the last minutes of trading --- if any of this means anything for the future.

The real future for the AVXL share price will be determined by the quality of the clinical results for blarcamesine against a) Rett syndrome (soon), b) Parkinson's disease dementia (later in 2022), and finally, c) Alzheimer's, in the trial ending in late 2022 or in earlier 2023.

I chuckle, smirk, and yawn while reading the ever so-helpful prognostications on the near-term AVXL share prices. Postings will be rather different when trial results appear. Anavex naysayers will say their nayings; we Anavex enthusiasts will post our interpretations. All the while, the AVXL share price will ascend.